Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390709
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-04-15
Brief Title:
PREDICT Therapy Selection for JAK T-cell or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier PREDICT
Sponsor:
Scipher Medicine
Organization:
Scipher Medicine
Study Overview
Official Title:
PREDICT Therapy Selection for JAK T-cell or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier PREDICT
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PREDICT
Brief Summary:
Prospective multi-center-observational study conducted within the US collecting patient samples for research and development to train test and validate precision medicine classifiers These molecular signature response classifiers MSRC aim to predict response status to JAK T-cell and IL-6 inhibitor therapies in patients with rheumatoid arthritis RA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None